SPTAN-1: A Potential Drug Target and Biomarker (G84221)

Target Name: SPATC1L

NCBI ID: G84221

SPATC1L

SPTAN-1: A Potential Drug Target and Biomarker

SPATC1L (SPATC1L variant 2) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the SPTAN family, which includes proteins that are involved in the regulation of stem cell proliferation and differentiation.

SPATC1L variant 2 is a genetic variation in the SPTAN gene that has been identified as a potential drug target or biomarker. The SPTAN gene is responsible for the production of a protein called SPTAN-1, which is involved in the regulation of stem cell proliferation and differentiation. The variation in SPTAN-1 has been shown to have a negative impact on the ability of stem cells to self-renew and form complete biological individuals.

Studies have suggested that SPTAN-1 plays a role in the regulation of cellular processes that are important for the development and maintenance of tissues and organs. For example, studies have shown that SPTAN-1 is involved in the regulation of cell death, and that it plays a role in the development of neurodegenerative diseases.

In addition to its potential role in the regulation of cellular processes, SPTAN-1 has also been shown to be involved in the regulation of stem cell proliferation. Studies have shown that SPTAN-1 plays a role in the regulation of the self-renewal ability of stem cells, and that it is involved in the development of stem cell-derived tissues and organs.

Given the potential role of SPTAN-1 in the regulation of cellular processes and the development of tissues and organs, researchers have been interested in using it as a drug target or biomarker. Studies have shown that SPTAN-1 is an attractive target for drug development due to its small size and the ease of its purification. In addition, studies have shown that SPTAN-1 is involved in the regulation of processes that are important for the development and maintenance of tissues and organs, which makes it an attractive target for the development of therapeutic agents.

In conclusion, SPATC1L (SPATC1L variant 2) is a protein that is expressed in various tissues of the body and is involved in the regulation of stem cell proliferation and differentiation. The SPTAN gene is responsible for the production of SPTAN-1, and variations in the SPTAN-1 gene have been shown to have a negative impact on the ability of stem cells to self-update and form complete biological entities. SPTAN-1 has also been shown to be involved in the regulation of cell death and the development of neurodegenerative diseases. As a result, SPTAN-1 is an attractive target for drug development due to its small size and the ease of its purification, and it is also an attractive biomarker for the development of therapeutic agents.

Protein Name: Spermatogenesis And Centriole Associated 1 Like

The "SPATC1L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SPATC1L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets